American Epilepsy Society

Type: Organization

Name: American Epilepsy Society

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Positive Phase III Results for Extended-Release Topiramate in Epilepsy Patients

Positive results have been reported from a global phase III study of extended-release topiramate (USL255; Upsher-Smith Laboratories) in adults with epilepsy. A new drug application (NDA) for the compound has been accepted for review by the FDA, with an ... [Published PT Community - May 23 2013]

Entities: Topiramate, Phase III, Epilepsy

First reported Nov 30 2012 - Updated Nov 30 2012 - 1 reports

BlackRock Inc

Blackrock NeuroMed Team Rolls Out Revolutionary EEG Monitoring Technology at the 2012 American Epilepsy Society Meeting

San Diego AES convention offers real-time demonstrations of CervelloTM Elite and CervelloTM ICU EEG Monitoring Technology December 1-3 Blackrock NeuroMed will demonstrate its revolutionary electrophysiology technology to the nation’s top neuroscientists, ... [Published PRWeb - Nov 30 2012]

Entities: BlackRock Inc, American Epilepsy Society, AES Corporation, Neuron, San Diego (California, United States)

Quotes

"Now in its twelfth year, the Antiepileptic Drug and Device Trials XII Conference spans the range of topics in epilepsy research and development as one of the leading scientific forums in the field. Offering the most current thinking on the treatment, diagnosis, global regulatory environment and therapies in development, AED XII provides a forum for the acceleration of new treatments and treatment practices that we hope will ultimately benefit people with epilepsy and seizure disorders" said Jacqueline French, MD, Director of the Epilepsy Study Consortium, Director of Clinical Trials at NYU's Comprehensive Epilepsy Center and current...

Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Hi ... [Published Miami Herald - May 06 2013]

More Content

sort by: Date \| Relevance
Positive Phase III Results for Extended-Release... [Published PT Community - May 23 2013]
Gena R. Ghearing, MD Represents Pennsylvania wi... [Published ECPlaza - May 22 2013]
NEWS FROM THE AAN ANNUAL MEETING: Is Minimally ... [Published Neurology Today - May 17 2013]
Alexza Pharmaceuticals to Present at Antiepilep... [Published Miami Herald - May 06 2013]
Alexza Pharmaceuticals to Present at Antiepilep... [Published Michigan Live - May 06 2013]
UCB Announces New Data to Increase Understandin... [Published PR Newswire: Health - Dec 04 2012]
Results of Long-Term, Open-Label Extension Stud... [Published Business Wire Health News - Dec 03 2012]
Three-Year Data From Sabril® (vigabatrin) Regis... [Published Business Wire Health News - Dec 03 2012]
Three-Year Data From Sabril® (vigabatrin) Regis... [Published EON Health & Medicine - Dec 03 2012]
Results of Long-Term, Open-Label Extension Stud... [Published EON Health & Medicine - Dec 03 2012]
Results of Long-Term, Open-Label Extension Stud... [Published Business Wire Science: Science News - Dec 03 2012]
Three-Year Data From Sabril® (vigabatrin) Regis... [Published Business Wire Science: Science News - Dec 03 2012]
Upsher-Smith Presents Favorable Phase I Data fo... [Published PR Newswire: Health - Dec 03 2012]
Art Display Created by People with Epilepsy Hig... [Published EON Health & Medicine - Nov 30 2012]
Art Display Created by People with Epilepsy Hig... [Published Business Wire Science: Science News - Nov 30 2012]
Art Display Created by People with Epilepsy Hig... [Published Business Wire Health News - Nov 30 2012]
Blackrock NeuroMed Team Rolls Out Revolutionary... [Published PRWeb - Nov 30 2012]
UCB Announces New Data for VIMPAT® (lacosamide)... [Published PR Newswire: General Business - Nov 29 2012]
Emerging Data on USL261 (Intranasal Midazolam) ... [Published PR Newswire: Health - Nov 26 2012]